碳酸酐酶抑制剂哚唑拉胺（dorzolamide，商品名Trusopt）最近已由美国FDA批准以本品制成的2％眼药水用于治疗服内压过高（即开角型青光眼）患者。近些年来，在美国用于治疗开角型青光眼最常用的药物是民β-滞剂，此类药物是通过减、房水形成以降低眼内压，不妨碍视力，．且通常 The carbonic anhydrase inhibitor dorzolamide (trade name Trusopt) has recently been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with over-pressured (open-angle glaucoma) with a 2% ophthalmic solution of this product. In recent years, the most commonly used drugs used to treat open-angle glaucoma in the United States are β-defibrillators. These drugs are formed by reduction and aqueous humor to reduce intraocular pressure without disturbing visual acuity. And usually